Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
Carpal Tunnel Syndrome, Ibuprofen, Pain Management
About this trial
This is an interventional supportive care trial for Carpal Tunnel Syndrome
Eligibility Criteria
Inclusion Criteria:
- Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
- Full understanding of written and spoken Spanish (language).
- Participants must freely consent to participate.
- The presence of positive Phalen and Tinel signs.
- The presence of carpal tunnel syndrome signs and symptoms.
Exclusion Criteria:
• The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, , deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy (or contraindication) to non steroidal anti inflammatory drugs (NSAID), and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive).
Sites / Locations
- Centro Médico y de Especialidades Pediátricas Dr. José Gregorio Hernández
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Ibuprofen
Control group
Oral tablet pharmaceutical treatment. Participants will be treated with a maximum of 1200 mg per day, subdivided in 3 intakes of 400 mg each 8 hours during a time lapse of 4 weeks.
Waiting list control group. Participants that belong to the no intervention arm will be assigned to a waiting list to receive treatment. The participants will not receive treatment for carpal tunnel syndrome during a time lapse of 4 weeks. After this period of time, participants will begin the best treatment available.